Academic literature on the topic 'NF-kappa B pathway'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'NF-kappa B pathway.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Dissertations / Theses on the topic "NF-kappa B pathway"

1

陳俊峯 and Chun-fung Anthony Chan. "Dysregulation of nuclear factor-kappa B (NF-KB) signaling pathway in hepatocellular carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B31227156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lupica, Joseph A. "Inhibition of the NF-kB signaling pathway and its effects on apoptosis and cancer." Cleveland, Ohio : Cleveland State University, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=csu1214235115.

Full text
Abstract:
Thesis (Ph.D.)--Cleveland State University, 2008.<br>Abstract. Title from PDF t.p. (viewed on Oct. 6, 2008). Includes bibliographical references (p. 213-240). Available online via the OhioLINK ETD Center. Also available in print.
APA, Harvard, Vancouver, ISO, and other styles
3

Guo, Xiaoxia. "Nuclear Factor Kappa B Pathway and human cancer therapeutics." Thesis, University of Wolverhampton, 2009. http://hdl.handle.net/2436/88553.

Full text
Abstract:
Cancer is one of the major causes of morbidity in the world. Although the overall survival of cancer has been significantly improved by chemotherapy in the last three decades, the success of cancer chemotherapy is still severely limited by the lack of selectivity of anti-cancer drugs to malignant cells leading to dose-limiting toxicity and the resistance of cancer cells to the conventional anti-cancer drugs. Gene-directed enzyme prodrug therapy (GDEPT) was designed to direct the anti-cancer drugs to specifically target the cancer cells by using cancer specific promoter to drive the expression
APA, Harvard, Vancouver, ISO, and other styles
4

Sunami, Yoshiaki. "Molecular analysis of the non-canonical NF-kappaB pathway." Université Louis Pasteur (Strasbourg) (1971-2008), 2006. http://www.theses.fr/2006STR13177.

Full text
Abstract:
On a montré ici que les voies canonique/non-canonique de NF-B ne sont pas indépendantes et qu’un rôle principal de la voie canonique est l’activation des acteurs de la voie non-canonique. La traduction est requise et la stimulation par LPS régule positivement un éventuel intermédiaire dans la signalisation par LPS/CD40 qui supporte l'activation de la voie non-canonique. De plus, la voie non-canonique est constitutivement activée dans les cellules de HL, impliquant la phosphorylation persistante de p100. L'activation transitoire et constitutive de la voie non-canonique implique l'incorporation
APA, Harvard, Vancouver, ISO, and other styles
5

Torrie, Lindsay J. "Characterisation of the lipopolysaccharide stimulated NF#kappa#B signal transduction pathway in rat aortic smooth muscle cell." Thesis, University of Strathclyde, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249146.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Konieczkowski, David Joseph. "Systematic approaches to overcoming limitations of MAPK pathway inhibition in melanoma." Thesis, Harvard University, 2013. http://dissertations.umi.com/gsas.harvard:11094.

Full text
Abstract:
Metastatic melanoma is an aggressive, incurable cancer with historically few therapeutic options. The discovery that 60% of melanomas harbor the oncogenic BRAF_V600E mutation, which constitutively activates the MAPK pathway, has provided a promising new therapeutic axis. Although MAPK pathway inhibitor therapy has shown striking clinical results in BRAF_V600-mutant melanoma, this approach faces three limitations. First, 10-20% of BRAF_V600-mutant melanomas never achieve meaningful response to MAPK pathway inhibitor therapy (intrinsic resistance). Second, among BRAF_V600-mutant melanomas in
APA, Harvard, Vancouver, ISO, and other styles
7

Bu, De-xiu. "The nuclear factor k[kappa]B signal transduction pathway : its role in atherogenesis and intimal hyperplasia /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-615-8/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cai, Chunhui, and 蔡春晖. "TAK1 promotes ovarian cancer aggressiveness through activation of NF-kB pathway." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193410.

Full text
Abstract:
Ovarian cancer is one of the most deadly female malignancies. Despite advances in the treatment of ovarian cancer for the past decade, the cure rate of this disease is moderately improved. Emerging evidence suggests the molecular personalized therapeutic approach become popular for human cancer treatment. The nuclear factor-kappa B (NF-κB) signaling pathway has been shown to play multiple roles in cancer progression such as anti-apoptosis, cell cycle, angiogenesis and metastasis. This study attempted to characterize the functional roles of transforming growth factor (TGF)-β-activating kinase 1
APA, Harvard, Vancouver, ISO, and other styles
9

Shaikh, Raziya Banu. "Light related TNF cytokines and the NF-[kappa]B pathway in development and function of mucosal and NK T cells /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2003. http://wwwlib.umi.com/cr/ucsd/fullcit?p3091315.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cude, Kelly J. "Activation of a novel ERK5-NF-kappaB pathway is required for G2/M progression in the cell cycle /." Thesis, Connect to this title online; UW restricted, 2004. http://hdl.handle.net/1773/5003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!